U.S. Neurology Associates

What U.S. Neurology Associates does

U.S. Neurology Associates (USNA) is a privately held, U.S.-based partnership platform for community-based neurology practices, founded in 2023 and operating across Texas, Florida, and California with stated national expansion ambitions. The company enters into partnership or management services agreements with independent neurology practices, providing back-office infrastructure including payer contracting, revenue cycle management, staffing, compliance, chronic care management, and value-based care delivery. In parallel, USNA equips partner practices with an integrated portfolio of clinical ancillary services: in-office infusion therapy, specialty pharmacy dispensing, advanced imaging and diagnostics (including PET/CT and MRI), clinical trial operations for drug manufacturer sponsors, and clinical data aggregation/monetization partnerships with pharmaceutical companies.

Revenue is generated across five distinct streams: managed services fees from practice partnerships, payer contracting and value-based care arrangements, transaction-based revenue from specialty pharmacy and infusion services, professional services fees from sponsored clinical trials, and data monetization with drug manufacturers. Pricing is individually negotiated with partner practices and not publicly disclosed. The go-to-market is enterprise field sales and partner-led outreach: the company targets physician leaders and neurology groups via its website, direct contact forms, and partnership discussions, positioning itself as the leading national platform of community-based neurology practices delivering cutting-edge treatment options.

USNA is led by CEO Nitin Jain (formerly President of Value Based Care at U.S. Renal Care and Chief Operating Officer of Specialized Markets at Centene) and Chairman Brad Hively (former CEO of The Oncology Institute, which he took public in 2021). The company is privately held with no disclosed parent, investor, or funding rounds in the available source material, and the platform is currently focused on building out partner networks and operational scale rather than reporting financial metrics.

Name

U.S. Neurology Associates

Legal name

US Neurology Associates

Website

https://usneuroassoc.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

U.S. Neurology Associates is a private, partnership-driven healthcare platform founded in 2023 that provides practice management, back-office operations, and integrated ancillary services — including infusions, specialty pharmacy, diagnostics, clinical trials, and clinical data services — to community-based neurology practices in Texas, Florida, and California.

Ownership category

akta.pro rank

Product category

Neurology Practice Management Services

NAICS

Management Consulting Services (54161), Diagnostic Imaging Centers (621512)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Management Consulting Services (8742)

akta.pro primary industry

General Neurology (HLAKAIAA)

akta.pro secondary industries

Neurology & CNS Specialty Pharmaceuticals (HLAIACAC), Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS) (HSADAIAC)

Keywords

• Neurology practice management
• Specialty physician services
• Practice management platform
• Infusion therapy services
• Specialty pharmacy dispensing

Headquarters

HQ city

Plano

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Practice Management Fees: Revenue generated through management partnerships with neurology practices, providing back-office operations, administrative support, and operational efficiency services in exchange for management or partnership fees
2. Payer Contracting and Value-Based Care: Revenue from negotiated payer contracts and value-based care arrangements, potentially including shared savings arrangements with payers
3. Specialty Pharmacy and Infusion Services: Revenue from in-office infusion services and specialty pharmacy dispensing for neurological conditions
4. Clinical Trials: Revenue from conducting clinical trials for new drugs in partnership with sponsors (drug manufacturers)
5. Clinical Data Monetization: Revenue from aggregation and monetization of clinical data in partnership with drug manufacturers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Core offering

U.S. Neurology Associates is a national partnership platform for community-based neurology practices, providing comprehensive practice management, administrative support, and integrated ancillary services. The company partners with neurologists to take on operational burdens while delivering cutting-edge treatments including in-office infusions, specialty pharmacy dispensing, clinical trials, advanced imaging and diagnostics, and clinical data services. Currently operating in Texas, Florida, and California with national expansion plans.

Product overview

U.S. Neurology Associates is a partnership-driven national neurology platform designed to support community-based neurology practices. The company offers an integrated portfolio of clinical and administrative services including in-office infusions, specialty pharmacy, clinical trials, advanced imaging and diagnostics (PET/CT, MRI), clinical data services, therapy, and laboratory services. On the operational side, the platform provides payer contracting, value-based care models, chronic care management, revenue cycle management, and staffing support. Neurologists partner with US Neurology Associates to access cutting-edge treatments and ancillary services while the platform manages back-office operations and practice growth.

Differentiator

Problem solved

Functional benefit

Products and services

• In-Office Infusions In-office infusion services for neurological conditions and other diseases, enabling patients to receive treatment within the practice setting through the neurology platform's integrated infusion infrastructure.
• Specialty Pharmacy Dispensing of specialty drugs prescribed by the neurologist network, providing integrated pharmaceutical access for patients treated at partner neurology practices.
• Clinical Trials Conducting clinical trials for new drugs in partnership with pharmaceutical sponsors, enabling patient access to experimental treatments and generating revenue through trial participation.
• Imaging and Diagnostics Advanced imaging services including PET/CT and MRI, along with other diagnostic tools used by neurologists for patient assessment within the practice network.
• Clinical Data Services Aggregation and monetization of clinical data in partnership with drug manufacturers to support research and generate healthcare insights across the neurology practice network.
• Payer Contracting Negotiation and management of payer contracts to secure favorable reimbursement terms for partner neurology practices through collective bargaining leverage.
• Value-Based Care Value-based care delivery model focused on quality outcomes and cost efficiency in neurological treatment, including shared savings arrangements with payers.
• Chronic Care Management Ongoing care management programs for patients with chronic neurological conditions designed to improve outcomes and coordination across the care continuum.
• Therapy Services Therapeutic services for neurological patients as part of comprehensive care delivery within the partner practice network.
• Laboratory Services Lab testing services integrated into the practice for comprehensive neurological patient assessment across the partner network.
• Operational Support Back-office operational support including staffing, compliance, and payer contracting to alleviate administrative burden on neurologists at partner practices.
• Revenue Cycle Management Financial and administrative management of billing, collections, and reimbursement processes for partner neurology practices.

Quantifiable outcome

• Significantly increased physician compensation through reduced administrative burdens and optimized practice operations
• +1 more outcomes

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core and supporting.

• Drug Manufacturers (Pharmaceutical Companies)coreStrategic or Co-development PartnerPartnership with drug manufacturers for conducting clinical trials for new drugs and clinical data aggregation and monetization. The company leverages its network of neurologist partners to support drug development and research while generating revenue through trial participation and data services.
• Payers (Insurance Companies)coreStrategic or Co-development PartnerPayer contracting relationships for value-based care arrangements and negotiated contracts. The company leverages its national platform scale to negotiate favorable payer contracts on behalf of partner practices, improving reimbursement rates and enabling value-based care delivery models.
• Suppliers (Medical and Pharmaceutical Suppliers)supportingChannel Partner/ Reseller/ DistributorSupplier partnerships for favorable pricing and supply chain optimization. The company leverages collective purchasing power across its neurology practice network to negotiate better terms with medical and pharmaceutical suppliers.

Scale indicators2 records

Recent moves4 records

Expansion highlights5 records

Broad incumbents

• Heritage Provider Network: Heritage Provider Network is a California-based integrated physician network that has historically partnered with risk-bearing physician groups. Chairman Brad Hively previously held a leadership role there, and the organization is a relevant California-anchored MSO comparable.
• Centene Corporation: Centene is a large managed care payer where CEO Nitin Jain previously served as COO of Specialized Markets. While Centene is a payer rather than a practice platform, its role as a potential payer counterparty and its specialty physician strategy make it a relevant comparable for understanding demand-side dynamics.

Direct peers

• agilon health: agilon health partners with primary care physician groups to manage total cost of care through value-based contracts. It is a comparable VBC-enabled specialty practice platform, with similar physician partnership economics and payer contract structures, though in primary care rather than neurology.
• Privia Health Group: Privia Health enables physician practices with technology, population health, and payer contracting support across multiple specialties. Its multi-specialty physician enablement model overlaps with USNA's practice management and value-based care offerings.
• US Oncology Network (McKesson): The US Oncology Network is one of the largest community oncology practice platforms in the US, providing practice management, payer contracting, and clinical research support. USNA's CEO previously led U.S. Oncology's expansion into adjacencies, and the network is the most established specialty MSO model against which USNA is being built.
• OneOncology: OneOncology is a national partnership platform for community oncology practices, offering practice management, payer contracting, and clinical trial access. It is structurally the closest oncology analog to USNA's neurology platform.
• U.S. Renal Care: U.S. Renal Care is a national kidney-care practice platform where CEO Nitin Jain most recently served as President of Value-Based Care. The platform structure — aggregating specialty practices and moving them into risk-based arrangements — directly mirrors the USNA model.
• The Oncology Institute: The Oncology Institute is a value-based community oncology practice platform that went public in 2021 at a ~$1B market cap. USNA's chairman Brad Hively previously led TOI and is applying the same playbook to neurology, making TOI the closest functional and strategic comparable.

Emerging players

• ChenMed: ChenMed is a physician-led, value-based primary care platform serving complex elderly patients through owned clinics. Its physician-aligned VBC model and senior-focused chronic care management are conceptually aligned with USNA's chronic care management component.
• Cano Health: Cano Health is a value-based primary care platform with a heavy concentration in Florida and other senior-focused markets. It demonstrates both the upside and the execution risk of building a multi-state VBC physician platform, making it a useful emerging comparable for USNA.

Market position

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about U.S. Neurology Associates